Ameriprise Financial Inc Ngm Biopharmaceuticals Inc Transaction History

Ameriprise Financial Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.6 - $1.31 $21,204 - $46,295	35,340 Added 43.41%	116,751 $100,000
Q2 2023 Aug 14, 2023	SELL	$2.44 - $4.53 $5,370 - $9,970	-2,201 Reduced 2.63%	81,411 $210,000
Q1 2023 May 15, 2023	BUY	$3.72 - $5.4 $131,037 - $190,215	35,225 Added 72.8%	83,612 $341,000
Q4 2022 Feb 14, 2023	BUY	$3.41 - $12.93 $164,999 - $625,643	48,387 New	48,387 $242,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.